v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities    
Net loss $ (21,479,903) $ (11,402,070)
Adjustments to reconcile net loss to net cash used in operating activities:    
Reclassification of cumulative translation adjustment upon liquidation of foreign subsidiary 693,804
Share-based compensation 7,648,697 714,980
Stock option expense (69,992) 1,245,295
Depreciation and amortization 167,628 662,876
Provision for expected credit losses 13,462
Inventory write-down 67,050 30,866
Accretion expense 24,680 161,040
Gain on settlement of debt related to the sale of intellectual property – related party (348,966)
Change in fair value of convertible debt (21,000)
Unrealized gain on marketable securities (32,323)
Gain on settlement of note payable - silent partnership (111,940) (3,451)
Gain on sale and disposal of assets (262,083)
Non-cash lease expense 1,228,938 206,415
Changes in operating assets and liabilities:    
Accounts receivable, net (715,596) 5,988
Accounts receivable - related party 61,030 17,238
Inventories 197,090 (146,770)
Prepaid expenses and other assets (1,100,224) 1,054,592
Accounts payable and accrued liabilities 424,184 (1,535,900)
Accounts payable and accrued expense - related party (13,956) (982)
Intellectual property acquisition liability 750,000
Operating lease liabilities (1,297,977) (260,241)
Net cash used in operating activities (14,156,397) (9,271,124)
Cash Flows From Investing Activities    
Acquisition of Arcade Technology LLC and Arcade Realty LLC (4,180,000)
Payment for intangible asset (500,000) (400,000)
Payment for intangible asset - related party (350,000) (400,000)
Purchase of property and equipment (137,457) (1,216)
Proceeds from sales of assets 1,250,000
Other investing cash flows 3,174
Purchase of marketable securities (99,680)
Net cash used in investing activities (4,017,137) (798,042)
Cash Flows From Financing Activities    
Proceeds from exercise of pre-funded warrants 2,454
Proceeds from exercise of warrants 15,235,041
Proceeds from issuance of preferred shares 6,000,000
Proceeds from issuance of ordinary shares, pre-funded warrants and warrants, net 2,088,239 6,111,266
Repayments of convertible debt (61,339) (900,000)
Repayments on silent partnerships (803,940) (55,738)
Payments on loan payable (289,059) (176,814)
Net cash provided by financing activities 22,168,942 4,981,168
Effect of changes in exchange rates 9,617 (25,871)
Net increase (decrease) in cash 4,005,025 (5,113,869)
Cash at beginning of period 889,091 6,235,669
Cash at end of period 4,894,116 1,121,800
Cash at end of period - continuing operations 4,860,697 1,026,654
Cash at end of period - discontinued operations 33,419 95,146
Supplemental cash flow information:    
Cash paid for interest 13,314 105,470
Cash paid for income taxes
Non-Cash Investing and Financing Activities    
Operating lease liabilities arising from obtaining right-of-use assets 363,926 322,378
Acquisition of intangible asset for structured payments 1,113,424
Issuance of ordinary shares for in-process research and development 3,258,449
Issuance of ordinary shares for conversion of preferred shares 37,068
Ordinary shares issued and issuable for acquisition of intellectual property $ 5,470,400